Remedex Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 24-10-2024
- Paid Up Capital ₹ 0.10 M
as on 24-10-2024
- Company Age 8 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 8.33 Cr
as on 24-10-2024
- Satisfied Charges ₹ 1.40 Cr
as on 24-10-2024
- Revenue 2.12%
(FY 2023)
- Profit 5.96%
(FY 2023)
- Ebitda -20.51%
(FY 2023)
- Net Worth 81.38%
(FY 2023)
- Total Assets 23.31%
(FY 2023)
About Remedex Pharma
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹8.33 Cr. The company has closed loans amounting to ₹1.40 Cr, as per Ministry of Corporate Affairs (MCA) records.
Salman Siddikh, Aleemkhan Nisarudeen, and Shibin Kamalabai serve as directors at the Company.
- CIN/LLPIN
U74999KL2016PTC047213
- Company No.
047213
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Nov 2016
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Thiruvananthapuram, Kerala, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Remedex Pharma Private Limited offer?
Remedex Pharma Private Limited offers a wide range of products and services, including Hand Sanitizer & Disinfectant, Alcohol Based Hand Sanitizer, Biocides, Chlorhexidine Gluconate, Pulse Oximeter, Glucometer & POCT Devices, Pulse Oximeter.
Who are the key members and board of directors at Remedex Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Salman Siddikh  | Managing Director | 07-Nov-2016 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Aleemkhan Nisarudeen | Director | 13-Nov-2019 | Current |
| Shibin Kamalabai | Director | 23-Aug-2021 | Current |
Financial Performance of Remedex Pharma.
Remedex Pharma Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 2.12% increase. The company also saw a slight improvement in profitability, with a 5.96% increase in profit. The company's net worth Soared by an impressive increase of 81.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Remedex Pharma?
In 2023, Remedex Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹83.35 M
₹14.00 M
Charges Breakdown by Lending Institutions
- Others : 5.63 Cr
- Hdfc Bank Limited : 2.70 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Oct 2023 | Hdfc Bank Limited | ₹2.70 Cr | Open |
| 26 Sep 2019 | Others | ₹4.97 Cr | Open |
| 29 Jan 2019 | Others | ₹6.60 M | Open |
| 18 Apr 2022 | Others | ₹9.00 M | Satisfied |
| 11 Jan 2021 | Axis Bank Limited | ₹5.00 M | Satisfied |
How Many Employees Work at Remedex Pharma?
Unlock and access historical data on people associated with Remedex Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Remedex Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Remedex Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
